| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aggressive superficial bladder cancer
|
Harland, S.J.
|
|
1994
|
30 |
7 |
p. 899-900
2 p.
|
artikel
|
| 2 |
A phase I–II study of N-(phosphonacetyl)-l-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancer
|
Jodrell, D.I
|
|
1994
|
30 |
7 |
p. 950-954
5 p.
|
artikel
|
| 3 |
A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma
|
Philip, P.A.
|
|
1994
|
30 |
7 |
p. 1027-1029
3 p.
|
artikel
|
| 4 |
A phase II study of piritrexim in patients with advanced squamous cell carcinoma of the head and neck
|
Degardin, M.
|
|
1994
|
30 |
7 |
p. 1044-1045
2 p.
|
artikel
|
| 5 |
Breast conservative surgery: Towards more personalised treatments
|
Costa, A.
|
|
1994
|
30 |
7 |
p. 900-902
3 p.
|
artikel
|
| 6 |
CA50 as a serum marker for pancreatic carcinoma: Comparison with CA19-9
|
Pasquali, C.
|
|
1994
|
30 |
7 |
p. 1042-1043
2 p.
|
artikel
|
| 7 |
Cancer registration in Madras Metropolitan Tumour Registry, India
|
Shanta, V.
|
|
1994
|
30 |
7 |
p. 974-978
5 p.
|
artikel
|
| 8 |
Cancer vaccines
|
Dalgleish, A.G.
|
|
1994
|
30 |
7 |
p. 1029-1035
7 p.
|
artikel
|
| 9 |
Carboplatin and α-2b interferon intraperitoneal combination as first-line treatment of minimal residual ovarian cancer. A pilot study
|
Frasci, G
|
|
1994
|
30 |
7 |
p. 946-950
5 p.
|
artikel
|
| 10 |
Clinical significance of cathepsin D in primary ovarian cancer
|
Scambia, G.
|
|
1994
|
30 |
7 |
p. 935-940
6 p.
|
artikel
|
| 11 |
Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer
|
Tominaga, T
|
|
1994
|
30 |
7 |
p. 959-964
6 p.
|
artikel
|
| 12 |
Dual effect of parity on breast cancer risk
|
Hsieh, C.
|
|
1994
|
30 |
7 |
p. 969-973
5 p.
|
artikel
|
| 13 |
Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma
|
Abad, A.
|
|
1994
|
30 |
7 |
p. 1043-
1 p.
|
artikel
|
| 14 |
Estimating the incidence of cancers in Switzerland: 1983–1987
|
Raymond, L.
|
|
1994
|
30 |
7 |
p. 978-982
5 p.
|
artikel
|
| 15 |
European Cancer Centre/NDDO postgrduate course on basic and current topics in anticancer drug development
|
|
|
1994
|
30 |
7 |
p. 1039-
1 p.
|
artikel
|
| 16 |
Evidence against involvement of APC mutation in papillary thyroid carcinoma
|
Curtis, L.
|
|
1994
|
30 |
7 |
p. 984-987
4 p.
|
artikel
|
| 17 |
Expression of P-glycoprotein and in vitro or in vivo resistance to doxorubicin and cisplatin in breast and ovarian cancers
|
Veneroni, S.
|
|
1994
|
30 |
7 |
p. 1002-1007
6 p.
|
artikel
|
| 18 |
Factors affecting sensitivity to EO9 in rodent and human tumour cells in vitro: DT-diaphorase activity and hypoxia
|
Robertson, N.
|
|
1994
|
30 |
7 |
p. 1013-1019
7 p.
|
artikel
|
| 19 |
Federico Spreafico
|
Garattini, Silvio
|
|
1994
|
30 |
7 |
p. 1038-
1 p.
|
artikel
|
| 20 |
Haematological toxicity of radiotherapy following high-dose chemotherapy and autologous bone marrow transplantation in patients with recurrent Hodgkin's disease
|
Price, A
|
|
1994
|
30 |
7 |
p. 903-907
5 p.
|
artikel
|
| 21 |
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—a randomised study
|
Bonneterre, J.
|
|
1994
|
30 |
7 |
p. 1041-
1 p.
|
artikel
|
| 22 |
5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy—a randomised study
|
Jantunen, I.
|
|
1994
|
30 |
7 |
p. 1041-1042
2 p.
|
artikel
|
| 23 |
Hypersomy of chromosome 15 with retrovirally rearranged c-myc, loss of germline c-myc and IgK/c-myc juxtaposition in a macrophage-monocytic tumour line
|
Imreh, S
|
|
1994
|
30 |
7 |
p. 994-1002
9 p.
|
artikel
|
| 24 |
IKA/European Cancer Centre/EPGSS International Congress. Colorectal cancer: From gene to cure
|
|
|
1994
|
30 |
7 |
p. 1038-
1 p.
|
artikel
|
| 25 |
Immunotherapy of metastatic melanoma with interferon-α and interleukin-2: Pattern of progression in responders and patients with stable disease with or without resection of residual lesions
|
Keilholz, U
|
|
1994
|
30 |
7 |
p. 955-958
4 p.
|
artikel
|
| 26 |
Increases in leucocyte and platelet counts induced by the alkyl phospholipid hexadecylphosphocholine
|
Pronk, L.C.
|
|
1994
|
30 |
7 |
p. 1019-1022
4 p.
|
artikel
|
| 27 |
Informed consent in European multicentre randomised clinical trials — Are patients really informed?
|
Williams, C.J.
|
|
1994
|
30 |
7 |
p. 907-910
4 p.
|
artikel
|
| 28 |
Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer
|
Fountzilas, G.
|
|
1994
|
30 |
7 |
p. 965-969
5 p.
|
artikel
|
| 29 |
In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours
|
Larsson, R.
|
|
1994
|
30 |
7 |
p. 1022-1026
5 p.
|
artikel
|
| 30 |
Is informed consent essential for all chemotherapy studies?
|
Tobias, J.S.
|
|
1994
|
30 |
7 |
p. 897-899
3 p.
|
artikel
|
| 31 |
Low-dose γ-interferon therapy is ineffective in renal cell carcinoma patients with large tumour burden
|
Aulitzky, W.E
|
|
1994
|
30 |
7 |
p. 940-945
6 p.
|
artikel
|
| 32 |
MDM2 gene amplification in human breast cancer
|
Quesnel, B.
|
|
1994
|
30 |
7 |
p. 982-984
3 p.
|
artikel
|
| 33 |
Multimodal treatment of locally advanced transitional cell bladder carcinoma in elderly patients
|
Veronesi, A
|
|
1994
|
30 |
7 |
p. 918-920
3 p.
|
artikel
|
| 34 |
Pathology of the breast
|
Millis, R.R.
|
|
1994
|
30 |
7 |
p. 1036-
1 p.
|
artikel
|
| 35 |
Phase II trial of flutamide in advanced ovarian cancer: an EORTC Gynaecological Cancer Cooperative Group study
|
Tumolo, S
|
|
1994
|
30 |
7 |
p. 911-914
4 p.
|
artikel
|
| 36 |
Prognosis and treatment of T1G3 bladder tumours. A prognostic factor analysis of 121 patients
|
Mulders, P.F.A.
|
|
1994
|
30 |
7 |
p. 914-917
4 p.
|
artikel
|
| 37 |
Prognosis of breast cancer in males: an analysis of 170 cases
|
Salvadori, B.
|
|
1994
|
30 |
7 |
p. 930-935
6 p.
|
artikel
|
| 38 |
Prognostic factors in inflammatory breast cancer and therapeutic implications
|
Palangie, T.
|
|
1994
|
30 |
7 |
p. 921-927
7 p.
|
artikel
|
| 39 |
Prognostic significance of Epstein-Barr virus association in Hodgkin's disease
|
Armstrong, A.A.
|
|
1994
|
30 |
7 |
p. 1045-1046
2 p.
|
artikel
|
| 40 |
Prognostic value of a breast cancer-associated glycoprotein detected by monoclonal antibody LU-BCRU-G7
|
Rye, P.D
|
|
1994
|
30 |
7 |
p. 1007-1012
6 p.
|
artikel
|
| 41 |
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck
|
Colella, E.
|
|
1994
|
30 |
7 |
p. 928-930
3 p.
|
artikel
|
| 42 |
Recent developments in immune diagnosis and therapy of paraneoplastic neurological disease—A satellite meeting
|
|
|
1994
|
30 |
7 |
p. 1038-
1 p.
|
artikel
|
| 43 |
Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas
|
Manenti, G.
|
|
1994
|
30 |
7 |
p. 987-993
7 p.
|
artikel
|
| 44 |
The Seventh International Symposium on Platinum and Other Metal Compounds in Cancer Chemotherapy
|
|
|
1994
|
30 |
7 |
p. 1038-
1 p.
|
artikel
|
| 45 |
The Sixth International Conference on Topoisomerases: From Molecular Aspects to Clinical Application
|
|
|
1994
|
30 |
7 |
p. 1039-
1 p.
|
artikel
|
| 46 |
5th International Conference on Adjuvant Therapy of Primary Breast Cancer
|
|
|
1994
|
30 |
7 |
p. 1039-
1 p.
|
artikel
|
| 47 |
Third Central European Lung Cancer Conference
|
|
|
1994
|
30 |
7 |
p. 1039-
1 p.
|
artikel
|
| 48 |
Third International Symposium on Myelodysplastic Syndromes
|
|
|
1994
|
30 |
7 |
p. 1038-
1 p.
|
artikel
|
| 49 |
19th LH Gray Conference: Quantitative Imaging in Oncology
|
|
|
1994
|
30 |
7 |
p. 1039-
1 p.
|
artikel
|
| 50 |
Unusual clonal evolution during blast crisis of chronic myeloid leukaemia (CML)
|
Christodoulidou, F.
|
|
1994
|
30 |
7 |
p. 1040-1041
2 p.
|
artikel
|
| 51 |
Vasectomy and testicular cancer
|
Dieckmann, K.P.
|
|
1994
|
30 |
7 |
p. 1039-1040
2 p.
|
artikel
|
Tijdschrift beschrijving